1.39 USD
▼-0.06-4.14%
盘后 1.32 -5.12%
2026-11-20
市值
$1.30M
市盈率
—
EPS
-38.49
股息率
—
52 周区间
1.30 – 179.19
成交量
51.93K
Beta
-0.01
目标价
—
52W 低 1.3052W 高 179.19
价格走势
公司简介
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and inso...